Concepedia

Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice

Ethaar El‐Emir, Geoffrey M. Boxer, Ingrid A. Petrie, R Boden, Jason L.J. Dearling, Richard H. J. Beǵent, R. Barbara Pedley

European Journal of Cancer · 2005 · 59 citations · 29 references

DOI

Concepts

References

29

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

George R. Pettit, Sheo B. Singh, Ernest Hamel et al. · Cellular and Molecular Life Sciences · 1989 · 789 citations

, , +11

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

G. Dark, S A Hill, Vivien E. Prise et al. · PubMed · 1997 · 624 citations

, , +13

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

Afshin Dowlati, Kelly M. Robertson, Matthew M. Cooney et al. · PubMed · 2002 · 406 citations

, , +17

Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.

G. M. Tozer, Vivien E. Prise, John Wilson et al. · PubMed · 1999 · 324 citations

, , +17

Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate.

David J. Chaplin, George R. Pettit, S A Hill · PubMed · 1999 · 252 citations

, , +17